Nomura Research Institute, Ltd.
NURAF
$37.72
-$0.88-2.28%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 5.01B | 5.02B | 5.10B | 5.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 5.01B | 5.02B | 5.10B | 5.18B |
| Cost of Revenue | -- | 3.22B | 3.24B | 3.29B | 3.36B |
| Gross Profit | -- | 1.78B | 1.78B | 1.81B | 1.82B |
| SG&A Expenses | -- | 964.53M | 962.53M | 986.06M | 985.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -20.29M | -16.76M | -1.50M | 2.40M |
| Total Operating Expenses | -- | 4.17B | 4.18B | 4.28B | 4.35B |
| Operating Income | -- | 837.08M | 835.72M | 823.12M | 829.23M |
| Income Before Tax | -- | 833.52M | 823.19M | 811.24M | 827.47M |
| Income Tax Expenses | -- | 245.78M | 251.69M | 257.01M | 238.87M |
| Earnings from Continuing Operations | -- | 587.74 | 571.50 | 554.23 | 588.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -3.80M | -4.02M | -3.56M | -2.07M |
| Net Income | -- | 583.94M | 567.48M | 550.67M | 586.52M |
| EBIT | -- | 837.08M | 835.72M | 823.12M | 829.23M |
| EBITDA | -- | 1.16B | 1.16B | 1.16B | 1.17B |
| EPS Basic | -- | 1.01 | 0.98 | 0.95 | 1.00 |
| Normalized Basic EPS | -- | 0.67 | 0.66 | 0.86 | 0.86 |
| EPS Diluted | -- | 1.01 | 0.98 | 0.95 | 1.00 |
| Normalized Diluted EPS | -- | 0.67 | 0.66 | 0.86 | 0.86 |
| Average Basic Shares Outstanding | -- | 2.30B | 2.31B | 2.33B | 2.35B |
| Average Diluted Shares Outstanding | -- | 2.30B | 2.31B | 2.33B | 2.35B |
| Dividend Per Share | -- | 0.39 | 0.36 | 0.36 | 0.34 |
| Payout Ratio | -- | 34.50% | 35.50% | 35.24% | 33.11% |